Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2015 first quarter ended September 30 of $24.1 billion, a decrease of 2 percent compared to the same period a year ago. Profit decreased 22 percent to $266 million.
Pharmaceutical segment sales decreased 3 percent year-over-year to $21.2 billion. The decrease in pharmaceutical sales was driven by the expiration of the Walgreens contract in the prior year first quarter. The decline was partially offset by growth from new and existing customers as well as continued strong growth in China. Medical segment sales grew 5 percent to $2.9 billion driven by acquisitions.